secwatch.observer — SEC 8-K summary
======================================

Issuer:     iRhythm Holdings, Inc. (IRTC)
CIK:        0001388658
Form:       8-K
Filed at:   2023-05-30T23:59:59+00:00
Accession:  0001388658-23-000070
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

FDA warning letter to iRhythm for Zio AT System quality and reporting violations
--------------------------------------------------------------------------------

- FDA alleges non-conformities in medical device reporting and quality system requirements for Zio AT System.
- Warning letter follows August 2022 inspection of iRhythm's Cypress, CA facility; company intends to respond within specified timeframe.
- Company has taken corrective measures on prior FDA Form 483 observations and will continue remediation efforts.
- Warning letter does not restrict manufacturing, production, or shipment of products in U.S. or require product withdrawal at this time.
- iRhythm believes no material financial impact absent further adverse FDA action, but additional regulatory actions remain possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1388658/000138865823000070/0001388658-23-000070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1388658/000138865823000070/irtc-20230525.htm
  HTML page:      https://secwatch.observer/filing/0001388658-23-000070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer